News & Articles

Look back at some of the best life sciences content SelectScience has covered in 2019

In this on-demand webinar, find out the latest methods for equines anti-doping analysis, and the analysis of challenging samples

Learn how quantitative DBS technology could transform the clinical utility of dried blood spots and help drive the shift to self-sampling in healthcare

Paul Andrews, National Phenotypic Screening Centre, discusses challenges and trends in cellular modeling of disease

Hear from James Grinias, the 2022 winner of the Emerging Leader in Chromatography Award

SelectScience reflects on the biggest life sciences stories and best life sciences content of the year

Scientists from Abu Dhabi’s RASID lab provide an insider’s look at the high-throughput wastewater analysis facility

The challenges and hurdles of integrating MALDI-TOF, and its impact on patient care

A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics

Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1st September 2025

MaxCyte’s Flow Electroporation technology and ExPERT platform to support the development of Adicet’s gamma delta T cell therapy gene edited programs

AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, neurofilament and APOE genotype in Alzheimer’s disease diagnostics

Direct, high-resolution imaging of cells on membrane inserts without removal or disruption

Dr. Michael Kiebish of BPGbio shares insight into its AI-powered NAi Interrogative Biology Platform and discusses the growing importance of multiomic data

Enhance sample traceability, streamline inventory, and support compliance with a trusted, user-friendly LIMS solution

46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits

First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat

From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing

Crown Bioscience’s in vitro model offers a physiologically relevant tool to evaluate drug efficacy for hematological diseases

The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept

New findings at ADLM 2025 could remedy this failure

Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025

Discover how Waters' HRMS innovations are enhancing the accuracy and scope of PFAS detection and analysis